Case Studies Of Phase 2 Adaptive Dose-Finding Trials - Jim Bolognese

Case Studies of Phase 2 Adaptive Dose-Finding Trials - Jim Bolognese

Adaptive Dose-Finding Designs: Improving Development Strategies

Adaptive Dose Finding Using Toxicity Probability Intervals - Neby Bekele

Determining the Optimal Development Path

Accelerating Early Stage Develpment with Simulation and Biomarkers

Speeding Early Development with Simulation and Biomarkers

ECO2018 A Randomised, Phase 2, Placebo and Active Controlled Dose Ranging Study of Semaglutide For

Phase 1 Dose Escalation: Introduction to Adaptive Trial Designs using FACTS

Berry Consultants

A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology - Satrajit Roychoudhury

Pharmacometrics Phase 2 Proof-Of-Concept Dose Selection Phase 3/Marketing

Simulations Plus, Inc.

Adaptivo™ Case Studies: Clinical Example 2

Standard Imaging

Seamless Phase 2/3 Trials: Introduction to Adaptive Trial Designs using FACTS

Berry Consultants

Model-based Designs in Oncology Dose-finding Studies

A Competitive Alternative to Model-based Dose Escalation Procedures

Blinded Adaptations, Permutation Tests, and T-tests - Michael Proschan

Topics in the Estimation of Historical Control in Early Phase Oncology Trials - Lynn Navale

Phase II Clinical Trials

Cytel and Medidata: Optimizing Drug Supply Strategies with Simulations